<?xml version="1.0" encoding="utf-8" standalone="no"?>
<dublin_core schema="dc">
<dcvalue element="contributor" qualifier="author">Yoo,&#x20;Euna</dcvalue>
<dcvalue element="contributor" qualifier="author">Yoon,&#x20;Juhee</dcvalue>
<dcvalue element="contributor" qualifier="author">Pae,&#x20;Ae&#x20;Nim</dcvalue>
<dcvalue element="contributor" qualifier="author">Rhim,&#x20;Hyewhon</dcvalue>
<dcvalue element="contributor" qualifier="author">Park,&#x20;Woo-Kyu</dcvalue>
<dcvalue element="contributor" qualifier="author">Kong,&#x20;Jae&#x20;Yang</dcvalue>
<dcvalue element="contributor" qualifier="author">Choo,&#x20;Hea-Young&#x20;Park</dcvalue>
<dcvalue element="date" qualifier="accessioned">2024-01-20T20:00:39Z</dcvalue>
<dcvalue element="date" qualifier="available">2024-01-20T20:00:39Z</dcvalue>
<dcvalue element="date" qualifier="created">2021-09-02</dcvalue>
<dcvalue element="date" qualifier="issued">2010-02-15</dcvalue>
<dcvalue element="identifier" qualifier="issn">0968-0896</dcvalue>
<dcvalue element="identifier" qualifier="uri">https:&#x2F;&#x2F;pubs.kist.re.kr&#x2F;handle&#x2F;201004&#x2F;131713</dcvalue>
<dcvalue element="description" qualifier="abstract">A&#x20;novel&#x20;series&#x20;of&#x20;5-HT2A&#x20;ligands&#x20;that&#x20;contain&#x20;a&#x20;(phenylpiperazinyl-propyl)arylsulfonamides&#x20;skeleton&#x20;was&#x20;synthesized.&#x20;Thirty-seven&#x20;N-(cycloalkylmethyl)-4-methoxy-N-(3-(4-arylpiperazin-1-yl)propyl)arylsulfonamide&#x20;and&#x20;N-(4-(4-arylpiperazin-1-yl)butan-2-yl)-arylsulfonamide&#x20;compounds&#x20;were&#x20;obtained.&#x20;The&#x20;binding&#x20;of&#x20;these&#x20;compounds&#x20;to&#x20;the&#x20;5-HT2A,&#x20;5-HT2C,&#x20;and&#x20;5-HT7&#x20;receptors&#x20;was&#x20;evaluated.&#x20;Most&#x20;of&#x20;the&#x20;compounds&#x20;showed&#x20;IC50&#x20;values&#x20;of&#x20;less&#x20;than&#x20;100&#x20;nM&#x20;and&#x20;exhibited&#x20;high&#x20;selectivity&#x20;for&#x20;the&#x20;5-HT2A&#x20;receptor.&#x20;Among&#x20;the&#x20;synthesized&#x20;compounds,&#x20;16a&#x20;and&#x20;16d&#x20;showed&#x20;good&#x20;affinity&#x20;at&#x20;5-HT2A&#x20;(IC50&#x20;=&#x20;0.7&#x20;nM&#x20;and&#x20;0.5&#x20;nM)&#x20;and&#x20;good&#x20;selectivity&#x20;over&#x20;5-HT2C&#x20;(50-100&#x20;times)&#x20;and&#x20;5-HT7&#x20;(1500-3000&#x20;times).&#x20;(C)&#x20;2010&#x20;Elsevier&#x20;Ltd.&#x20;All&#x20;rights&#x20;reserved.</dcvalue>
<dcvalue element="language" qualifier="none">English</dcvalue>
<dcvalue element="publisher" qualifier="none">PERGAMON-ELSEVIER&#x20;SCIENCE&#x20;LTD</dcvalue>
<dcvalue element="subject" qualifier="none">SEROTONIN</dcvalue>
<dcvalue element="subject" qualifier="none">DERIVATIVES</dcvalue>
<dcvalue element="subject" qualifier="none">SCHIZOPHRENIA</dcvalue>
<dcvalue element="subject" qualifier="none">AFFINITY</dcvalue>
<dcvalue element="title" qualifier="none">Synthesis&#x20;and&#x20;biological&#x20;evaluation&#x20;of&#x20;(phenylpiperazinyl-propyl)arylsulfonamides&#x20;as&#x20;selective&#x20;5-HT2A&#x20;receptor&#x20;antagonists</dcvalue>
<dcvalue element="type" qualifier="none">Article</dcvalue>
<dcvalue element="identifier" qualifier="doi">10.1016&#x2F;j.bmc.2009.12.067</dcvalue>
<dcvalue element="description" qualifier="journalClass">1</dcvalue>
<dcvalue element="identifier" qualifier="bibliographicCitation">BIOORGANIC&#x20;&amp;&#x20;MEDICINAL&#x20;CHEMISTRY,&#x20;v.18,&#x20;no.4,&#x20;pp.1665&#x20;-&#x20;1675</dcvalue>
<dcvalue element="citation" qualifier="title">BIOORGANIC&#x20;&amp;&#x20;MEDICINAL&#x20;CHEMISTRY</dcvalue>
<dcvalue element="citation" qualifier="volume">18</dcvalue>
<dcvalue element="citation" qualifier="number">4</dcvalue>
<dcvalue element="citation" qualifier="startPage">1665</dcvalue>
<dcvalue element="citation" qualifier="endPage">1675</dcvalue>
<dcvalue element="description" qualifier="journalRegisteredClass">scie</dcvalue>
<dcvalue element="description" qualifier="journalRegisteredClass">scopus</dcvalue>
<dcvalue element="identifier" qualifier="wosid">000274425500032</dcvalue>
<dcvalue element="identifier" qualifier="scopusid">2-s2.0-75849120790</dcvalue>
<dcvalue element="relation" qualifier="journalWebOfScienceCategory">Biochemistry&#x20;&amp;&#x20;Molecular&#x20;Biology</dcvalue>
<dcvalue element="relation" qualifier="journalWebOfScienceCategory">Chemistry,&#x20;Medicinal</dcvalue>
<dcvalue element="relation" qualifier="journalWebOfScienceCategory">Chemistry,&#x20;Organic</dcvalue>
<dcvalue element="relation" qualifier="journalResearchArea">Biochemistry&#x20;&amp;&#x20;Molecular&#x20;Biology</dcvalue>
<dcvalue element="relation" qualifier="journalResearchArea">Pharmacology&#x20;&amp;&#x20;Pharmacy</dcvalue>
<dcvalue element="relation" qualifier="journalResearchArea">Chemistry</dcvalue>
<dcvalue element="type" qualifier="docType">Article</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">SEROTONIN</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">DERIVATIVES</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">SCHIZOPHRENIA</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">AFFINITY</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">5-HT2A&#x20;receptor&#x20;antagonists</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">Piperazine</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">Sulfonamide</dcvalue>
</dublin_core>
